Do you want to read an article? Please log in or register.
The Effect of Biologic and Targeted Synthetic Drugs on Work- and Productivity-related Outcomes for Patients with Psoriatic Arthritis: A Systematic Review
Psoriatic Arthritis
Related content
Rheumatoid Arthritis
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial
JAMA.
Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P
doi: 10.1001/jama.2016.13512.
Rheumatoid Arthritis
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
Ann Rheum Dis.
Chatzidionysiou K, Emamikia S, Nam J, Ramiro S, Smolen J, van der Heijde D, Dougados M, Bijlsma J, Burmester G, Scholte M, van Vollenhoven R, Landewé R
doi: 10.1136/annrheumdis-2016-210711.
Rheumatoid Arthritis
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study
Ann Rheum Dis.
Pappas DA, St John G, Etzel CJ, Fiore S, Blachley T, Kimura T, Punekar R, Emeanuru K, Choi J, Boklage S, Kremer JM
doi: 10.1136/annrheumdis-2020-217209.
Psoriasis
Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis
Br J Dermatol.
Zill JM, Christalle E, Tillenburg N, Mrowietz U, Augustin M, Härter M, Dirmaier J
doi: 10.1111/bjd.17272.
Rheumatoid Arthritis
Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
Rheumatology (Oxford).
Schlager L, Loiskandl M, Aletaha D, Radner H
doi: 10.1093/rheumatology/kez278.
Psoriatic Arthritis
Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis
Semin Arthritis Rheum.
Lu C, Wallace BI, Waljee AK, Fu W, Zhang Q, Liu Y
doi: 10.1016/j.semarthrit.
PsoriasisPsoriatic Arthritis
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis
JAMA Dermatol.
Vaengebjerg S, Skov L, Egeberg A, Loft ND
doi: 10.1001/jamadermatol.2020.0024.
Psoriatic Arthritis
Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis
Semin Arthritis Rheum.
Zusman EZ, Howren AM, Park JYE, Dutz J, De Vera MA
doi: 10.1016/j.semarthrit.2020.02.001.
COMMENTED
Rheumatoid Arthritis
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs
★ 3
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
doi: 10.1186/s13075-019-2059-8.